^“Distinct in vivo roles of colony-stimulating factor-1 isoforms in renal inflammation”. Journal of Immunology177 (6): 4055–63. (September 2006). doi:10.4049/jimmunol.177.6.4055. PMID16951369.
^“The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update”. Experimental Biology and Medicine229 (1): 1–11. (January 2004). doi:10.1177/153537020422900101. PMID14709771.
^“Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivo”. Kidney International85 (4): 794–806. (April 2014). doi:10.1038/ki.2013.341. PMID24048378.
“The biology and action of colony stimulating factor-1”. Stem Cells12 Suppl 1: 15–24; discussion 25. (1995). PMID7696959.
“Colony stimulating factor-1 expression in human glioma”. Molecular and Chemical Neuropathology21 (2–3): 177–88. (1994). doi:10.1007/BF02815350. PMID8086034.
“CSF-1 as a regulator of macrophage activation and immune responses”. Archivum Immunologiae et Therapiae Experimentalis51 (3): 169–77. (2004). PMID12894871.
“Hematopoietic cytokines as tumor markers”. Clinical Chemistry and Laboratory Medicine42 (12): 1347–54. (2005). doi:10.1515/CCLM.2004.253. PMID15576295.
“Identification of a high molecular weight macrophage colony-stimulating factor as a glycosaminoglycan-containing species”. The Journal of Biological Chemistry267 (7): 4345–8. (March 1992). doi:10.1016/S0021-9258(18)42841-4. PMID1531650.
“Reassignment of the human macrophage colony stimulating factor gene to chromosome 1p13-21”. Biochemical and Biophysical Research Communications182 (3): 1139–43. (February 1992). doi:10.1016/0006-291X(92)91850-P. PMID1540160.
“Macrophage colony-stimulating factor is produced by activated T lymphocytes in vitro and is detected in vivo in T cells from reactive lymph nodes”. Blood79 (9): 2500–1. (May 1992). doi:10.1182/blood.V79.9.2500.2500. PMID1571567.
“The predominant form of secreted colony stimulating factor-1 is a proteoglycan”. The Journal of Biological Chemistry267 (4): 2190–9. (February 1992). doi:10.1016/S0021-9258(18)45861-9. PMID1733926.
“Expression of colony-stimulating factor-1 (CSF-1) messenger RNA in human endometrial glands during the menstrual cycle: molecular cloning of a novel transcript that predicts a cell surface form of CSF-1”. Molecular Endocrinology5 (12): 1931–8. (December 1991). doi:10.1210/mend-5-12-1931. PMID1791839.
“Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by a plasma membrane-bound precursor of human CSF-1”. Blood76 (7): 1308–14. (October 1990). doi:10.1182/blood.V76.7.1308.1308. PMID2145044.
“The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1”. Cell41 (3): 665–76. (July 1985). doi:10.1016/S0092-8674(85)80047-7. PMID2408759.
“Human macrophage-colony stimulating factor: alternative RNA and protein processing from a single gene”. Molecular Immunology25 (8): 761–70. (August 1988). doi:10.1016/0161-5890(88)90112-5. PMID2460758.
“Amino-terminal region of human macrophage colony-stimulating factor (M-CSF) is sufficient for its in vitro biological activity: molecular cloning and expression of carboxyl-terminal deletion mutants of human M-CSF”. Biochemical and Biophysical Research Communications161 (2): 892–901. (June 1989). doi:10.1016/0006-291X(89)92683-1. PMID2660794.
“Macrophage colony-stimulating factor is produced by human T lymphoblastoid cell line, CEM-ON: identification by amino-terminal amino acid sequence analysis”. Biochemical and Biophysical Research Communications152 (3): 1401–9. (May 1988). doi:10.1016/S0006-291X(88)80441-8. PMID3259875.